Bank Of Stockton Bristol Myers Squibb CO Transaction History

Bank Of Stockton

$315 Million
Q2 2024

A detailed history of Bank Of Stockton transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank Of Stockton holds 6,023 shares of BMY stock, worth $295,909. This represents 0.08% of its overall portfolio holdings.

Number of Shares

6,023

Previous 6,360 5.3%

Holding current value

$295,909

Previous $344,000 27.33%

% of portfolio

0.08%

Previous 0.11%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$40.25 - $52.99 $13,564 - $17,857	-337 Reduced 5.3%	6,023 $250,000
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $3,393 - $4,049	-70 Reduced 1.09%	6,360 $326,000
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $45,038 - $50,359	-778 Reduced 10.79%	6,430 $373,000
Q2 2023 Jul 31, 2023	BUY	$63.71 - $70.74 $28,478 - $31,620	447 Added 6.61%	7,208 $460,000
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $31,212 - $35,401	-475 Reduced 6.56%	6,761 $468,000
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $6,848 - $8,109	-100 Reduced 1.36%	7,236 $521,000
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $676 - $810	11 Added 0.15%	7,336 $536,000
Q3 2021 Oct 18, 2021	SELL	$59.17 - $69.31 $710 - $831	-12 Reduced 0.16%	7,325 $433,000
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $21,668 - $23,597	-350 Reduced 4.55%	7,337 $490,000
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $26,703 - $30,032	-450 Reduced 5.53%	7,687 $485,000
Q4 2020 Jan 28, 2021	SELL	$57.74 - $65.43 $128,471 - $145,581	-2,225 Reduced 21.47%	8,137 $504,000
Q3 2020 Nov 23, 2020	SELL	$57.43 - $63.64 $122,268 - $135,489	-2,129 Reduced 17.04%	10,362 $624,000
Q2 2020 Jul 23, 2020	BUY	$54.82 - $64.09 $206,671 - $241,619	3,770 Added 43.23%	12,491 $734,000
Q1 2020 Apr 07, 2020	SELL	$46.4 - $67.43 $5,475 - $7,956	-118 Reduced 1.33%	8,721 $486,000
Q4 2019 Feb 03, 2020	BUY	$49.21 - $64.19 $34,151 - $44,547	694 Added 8.52%	8,839 $567,000
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $104,187 - $123,529	-2,436 Reduced 23.02%	8,145 $413,000
Q2 2019 Jul 26, 2019	SELL	$44.62 - $49.34 $36,052 - $39,866	-808 Reduced 7.09%	10,581 $479,000
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $112,619 - $134,284	-2,496 Reduced 17.98%	11,389 $543,000
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $67,532 - $87,573	-1,385 Reduced 9.07%	13,885 $721,000
Q3 2018 Oct 09, 2018	SELL	$55.19 - $62.25 $3,035 - $3,423	-55 Reduced 0.36%	15,270 $947,000
Q2 2018 Jul 13, 2018	SELL	$50.53 - $62.98 $70,944 - $88,423	-1,404 Reduced 8.39%	15,325 $847,000
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $5,093 - $5,863	-85 Reduced 0.51%	16,729 $1.06 Million
Q4 2017 Jan 25, 2018	BUY	$59.94 - $65.35 $18,521 - $20,193	309 Added 1.87%	16,814 $1.03 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $911,571 - $1.05 Million	16,505	16,505 $1.05 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Stockton, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Stockton with notifications on news.

Account